Microcrystalline cellulose
- Generic Name
- Microcrystalline cellulose
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- 9004-34-6
- Unique Ingredient Identifier
- BX81F82EWG
- Background
A polysaccharide with glucose units linked as in CELLOBIOSE. It is the chief constituent of plant fibers, cotton being the purest natural form of the substance. As a raw material, it forms the basis for many derivatives used in chromatography, ion exchange materials, explosives manufacturing, and pharmaceutical preparations.
- Indication
用于体表创伤、外科创面止血及上消化道出血。
- Associated Conditions
- Vaginal burning sensation, Vaginal itching
- Associated Therapies
- -
KAND567 Versus Placebo in Subjects Hospitalized With COVID-19
- First Posted Date
- 2023-08-25
- Last Posted Date
- 2023-08-25
- Lead Sponsor
- Kancera AB
- Target Recruit Count
- 35
- Registration Number
- NCT06012565
- Locations
- 🇩🇰
Odense University Hospital, Odense, Denmark
🇩🇰Hvidovre Hospital, Hvidovre, Denmark
🇸🇪Västmanlands Hospital, Västerås, Sweden
Investigation of the Efficacy of Metformin Therapy on Pulmonary Sarcoidosis
- Conditions
- Interventions
- First Posted Date
- 2023-06-18
- Last Posted Date
- 2024-10-16
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 40
- Registration Number
- NCT05910554
Effectiveness of Food-grown Magnesium on Sleep Quality/Quantity
- Conditions
- Interventions
- First Posted Date
- 2023-04-24
- Last Posted Date
- 2023-10-24
- Lead Sponsor
- RDC Clinical Pty Ltd
- Target Recruit Count
- 84
- Registration Number
- NCT05825209
- Locations
- 🇦🇺
RDC Global Pty Ltd, Brisbane, Queensland, Australia
Effectiveness of PEA Compared to Placebo on Acute Menstrual Pain
- First Posted Date
- 2023-04-12
- Last Posted Date
- 2024-11-14
- Lead Sponsor
- RDC Clinical Pty Ltd
- Target Recruit Count
- 80
- Registration Number
- NCT05810116
- Locations
- 🇦🇺
RDC Clinical Pty Ltd, New Farm, Queensland, Australia
Effectiveness of Testofen Compared to Placebo on Long COVID Symptoms
- First Posted Date
- 2023-04-03
- Last Posted Date
- 2024-10-18
- Lead Sponsor
- RDC Clinical Pty Ltd
- Target Recruit Count
- 150
- Registration Number
- NCT05795816
- Locations
- 🇦🇺
RDC Clinical Pty Ltd, Brisbane, Queensland, Australia
Low Dose Naltrexone Use in Patients With POTS
- Conditions
- Interventions
- First Posted Date
- 2022-05-06
- Last Posted Date
- 2024-05-09
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 80
- Registration Number
- NCT05363514
A Phase I Study of GT300 in Healthy Subjects
- First Posted Date
- 2021-07-15
- Last Posted Date
- 2021-07-15
- Lead Sponsor
- Generian Pharmaceuticals, Inc.
- Target Recruit Count
- 56
- Registration Number
- NCT04963855
To Compare the Efficacy and Tolerability of A. Paniculata/A. Chilensis in Individuals With URTI
- Conditions
- Interventions
- First Posted Date
- 2021-07-08
- Last Posted Date
- 2022-05-10
- Lead Sponsor
- Vedic Lifesciences Pvt. Ltd.
- Target Recruit Count
- 225
- Registration Number
- NCT04955327
- Locations
- 🇮🇳
Shree Hospital & Critical Care Center, Nagpur, Maharashtra, India
🇮🇳Apollo Spectra Hospitals, Kanpur, Uttar Pradesh, India
🇮🇳Gillurkar Multispecialty Hospital, Nagpur, Maharashtra, India
Dronabinol for Pain and Inflammation in Adults Living With Sickle Cell Disease
- Conditions
- Interventions
- First Posted Date
- 2019-06-06
- Last Posted Date
- 2021-01-26
- Lead Sponsor
- Yale University
- Target Recruit Count
- 6
- Registration Number
- NCT03978156
- Locations
- 🇺🇸
Yale New Haven Hospital Smilow Cancer Center, New Haven, Connecticut, United States
Safety, Tolerability, Pharmacokinetics and Effects on Transcranial Magnetic Stimulation of Oral Doses of XEN1101
- Conditions
- Interventions
- First Posted Date
- 2018-03-16
- Last Posted Date
- 2018-09-18
- Lead Sponsor
- Xenon Pharmaceuticals Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT03468725
- Locations
- 🇬🇧
King's College Hospital, Brixton, London, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.